Evolus, Inc. (EOLS)
6.40
+0.08
(+1.27%)
USD |
NASDAQ |
May 07, 16:00
6.40
0.00 (0.00%)
After-Hours: 20:00
Evolus SG&A Expense (TTM) : 164.15M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Anika Therapeutics, Inc. | 53.95M |
| STAAR Surgical Co. | 185.99M |
| Quantum-Si, Inc. | 44.75M |
| Plus Therapeutics, Inc. | 12.13M |
| BioStem Technologies, Inc. | 132.72M |